Flemington, NJ, United States of America

Linda Mulcahy


Average Co-Inventor Count = 7.7

ph-index = 1

Forward Citations = 147(Granted Patents)


Location History:

  • Yardley, PA (US) (1998)
  • Flemington, NJ (US) (2000 - 2005)

Company Filing History:


Years Active: 1998-2005

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Linda Mulcahy

Introduction

Linda Mulcahy is a notable inventor based in Flemington, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of benign prostatic hyperplasia. With a total of 4 patents to her name, her work has the potential to impact many lives.

Latest Patents

One of her latest patents is focused on arylsubstituted piperazines that are useful in the treatment of benign prostatic hyperplasia. This invention relates to a series of arylsubstituted piperazines, of Formula I, and pharmaceutical compositions containing them, as well as intermediates used in their manufacture. The compounds of this invention selectively inhibit binding to the α-1a adrenergic receptor, which has been implicated in benign prostatic hyperplasia. As such, these compounds are potentially useful in the treatment of this and other diseases.

Career Highlights

Throughout her career, Linda has worked with reputable companies such as Ortho-McNeil Pharmaceutical Corporation and Affymax Technologies, N.V. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations.

Collaborations

Linda has collaborated with notable coworkers, including Linda K. Jolliffe and William V. Murray. These collaborations have likely enriched her work and expanded her impact in the field.

Conclusion

Linda Mulcahy's innovative contributions to pharmaceutical inventions demonstrate her commitment to improving healthcare solutions. Her patents and collaborations reflect her significant role in advancing medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…